1
|
Tang Y, Shen L, Bao J, Xu D. Deficiency of Tregs in hypertension-associated left ventricular hypertrophy. J Clin Hypertens (Greenwich) 2023; 25:562-572. [PMID: 37196041 PMCID: PMC10246464 DOI: 10.1111/jch.14660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2023] [Revised: 04/04/2023] [Accepted: 04/05/2023] [Indexed: 05/19/2023]
Abstract
Left ventricular hypertrophy (LVH) is the most common target organ damage in hypertension. Abnormal numbers or functions of CD4+ CD25+ Foxp3+ regulatory T lymphocytes (Tregs) can cause immune disorders, which participates in LVH. This study aimed to explore the role of Tregs in LVH by investigating circulating Tregs and associated cytokine levels in hypertensive patients with or without LVH. Blood samples were collected from 83 hypertensive patients without LVH (essential hypertension group, EH), 91 hypertensive patients with LVH (left ventricular hypertrophy group, LVH), and 69 normotensive controls without LVH (control group, CG). Tregs and cytokines were measured by flow cytometry and enzyme-linked immunosorbent assays. We found that circulating Tregs were significantly lower in hypertensive patients than in CG subjects. It was lower in LVH than in EH patients. No correlation between blood pressure regulation and Tregs was found in EH or LVH patients. Furthermore, Tregs in older females were lower than those in older males among LVH patients. Additionally, serum interleukin-10 (IL-10) and transforming growth factor beta 1 (TGFβ1) decreased in hypertensive patients, and interleukin-6 (IL-6) increased in LVH patients. Tregs were negatively correlated with creatine kinase, low-density lipoprotein cholesterol, apoprotein B, high-sensitivity C-reactive protein, and left ventricular mass index (LVMI) values. In general, our study demonstrates significantly decreased circulating Tregs in hypertensive LVH patients. Decreased circulating Tregs in LVH is independent of blood pressure regulation. IL-6, IL-10, and TGF-β1 are related with LVH in hypertension.
Collapse
Affiliation(s)
- Ying Tang
- Department of Internal Cardiovascular MedicineSecond Xiangya HospitalCentral South UniversityChangshaHunanChina
| | - Li Shen
- Department of Internal Cardiovascular MedicineSecond Xiangya HospitalCentral South UniversityChangshaHunanChina
| | - Jing‐hui Bao
- Department of Internal Cardiovascular MedicineSecond Xiangya HospitalCentral South UniversityChangshaHunanChina
| | - Dan‐Yan Xu
- Department of Internal Cardiovascular MedicineSecond Xiangya HospitalCentral South UniversityChangshaHunanChina
| |
Collapse
|
2
|
Balkrishna A, Rustagi Y, Bhattacharya K, Varshney A. Application of Zebrafish Model in the Suppression of Drug-Induced Cardiac Hypertrophy by Traditional Indian Medicine Yogendra Ras. Biomolecules 2020; 10:biom10040600. [PMID: 32295034 PMCID: PMC7226110 DOI: 10.3390/biom10040600] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2020] [Revised: 04/06/2020] [Accepted: 04/06/2020] [Indexed: 12/17/2022] Open
Abstract
Zebrafish is an elegant vertebrate employed to model the pathological etiologies of human maladies such as cardiac diseases. Persistent physiological stresses can induce abnormalities in heart functions such as cardiac hypertrophy (CH), which can lead to morbidity and mortality. In the present study, using zebrafish as a study model, efficacy of the traditional Indian Ayurveda medicine “Yogendra Ras” (YDR) was validated in ameliorating drug-induced cardiac hypertrophy. YDR was prepared using traditionally described methods and composed of nano- and micron-sized metal particles. Elemental composition analysis of YDR showed the presence of mainly Au, Sn, and Hg. Cardiac hypertrophy was induced in the zebrafish following a pretreatment with erythromycin (ERY), and the onset and reconciliation of disease by YDR were determined using a treadmill electrocardiogram, heart anatomy analysis, C-reactive protein release, and platelet aggregation time-analysis. YDR treatment of CH-induced zebrafish showed comparable results with the Standard-of-care drug, verapamil, tested in parallel. Under in-vitro conditions, treatment of isoproterenol (ISP)-stimulated murine cardiomyocytes (H9C2) with YDR resulted in the suppression of drug-stimulated biomarkers of oxidative stress: COX-2, NOX-2, NOX-4, ANF, troponin-I, -T, and cardiolipin. Taken together, zebrafish showed a strong disposition as a model for studying the efficacy of Ayurvedic medicines towards drug-induced cardiopathies. YDR provided strong evidence for its capability in modulating drug-induced CH through the restoration of redox homeostasis and exhibited potential as a viable complementary therapy.
Collapse
Affiliation(s)
- Acharya Balkrishna
- Drug Discovery and Development Division, Patanjali Research Institute, Haridwar 249 401, India
- Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Haridwar 249 401, India
| | - Yashika Rustagi
- Drug Discovery and Development Division, Patanjali Research Institute, Haridwar 249 401, India
| | - Kunal Bhattacharya
- Drug Discovery and Development Division, Patanjali Research Institute, Haridwar 249 401, India
- Correspondence: (K.B.); (A.V.); Tel.: +91-1334-244107 (K.B. & A.V.); Fax: +91-1334-244805 (K.B. & A.V.)
| | - Anurag Varshney
- Drug Discovery and Development Division, Patanjali Research Institute, Haridwar 249 401, India
- Department of Allied and Applied Sciences, University of Patanjali, Patanjali Yog Peeth, Haridwar 249 401, India
- Correspondence: (K.B.); (A.V.); Tel.: +91-1334-244107 (K.B. & A.V.); Fax: +91-1334-244805 (K.B. & A.V.)
| |
Collapse
|
3
|
Ghane Sharbaf F, Assadi F. Effect of allopurinol on the glomerular filtration rate of children with chronic kidney disease. Pediatr Nephrol 2018; 33:1405-1409. [PMID: 29549464 DOI: 10.1007/s00467-018-3943-1] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/14/2017] [Revised: 02/07/2018] [Accepted: 03/05/2018] [Indexed: 10/17/2022]
Abstract
BACKGROUND Hyperuricemia is a leading risk factor for the development of chronic kidney disease (CKD). We hypothesized that lowering serum uric acid (SUA) with allopurinol in hyperuricemic children with CKD may reduce the risk of CKD progression. METHODS A total of 70 children, aged 3-15 years, with elevated serum uric acid level (SUA) > 5.5 mg/dL and CKD stages 1-3 were prospectively randomized to receive allopurinol 5 mg/kg/day (study group, n = 38) or no treatment (control group, n = 32) for 4 months. The primary and secondary outcomes were changes in estimated glomerular filtration rate (eGFR) (> 10 mL/min/1.73m2) and the SUA (> 1.0 mg/dL) from baseline values, respectively. RESULTS Baseline age, gender, blood pressure (BP), body mass index (BMI), SUA, high-sensitive C-reactive protein (hsCRP), and eGFR were similar in allopurinol and control subjects. Allopurinol treatment resulted in a decrease in SUA, a decrease in systolic and diastolic BP, a decrease in hsCRP, and an increase in eGFR compared with the baseline values (p < 0.05 for all). No significant difference was observed in the control hyperuricemic subjects. In multiple regression analysis after incorporating variables (age, gender, BMI, systolic and diastolic BP, CRP, and SUA), eGFR was independently related to SUA both before and after treatments (p = 0.03 vs. p = 0.02, respectively). All patients in the study group tolerated allopurinol, and there were no adverse reactions observed by physical examination or reported by patients. CONCLUSION Urate-lowering therapy with allopurinol, over a 4-month period, can improve renal function in children with CKD stages 1-3.
Collapse
Affiliation(s)
- Fatemeh Ghane Sharbaf
- Department of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
| | - Farahnak Assadi
- Department of Pediatrics, Division of Nephrology, Rush University Medical left, 445 East North Water Street, Suite 1804, Chicago, IL, USA.
| |
Collapse
|
4
|
Seyfeli E, Sarli B, Saglam H, Karatas CY, Ozkan E, Ugurlu M. The Relationship Between High-Sensitivity C-Reactive Protein Levels and Left Ventricular Hypertrophy in Patients With Newly Diagnosed Hypertension. J Clin Hypertens (Greenwich) 2015; 18:679-84. [PMID: 26603359 DOI: 10.1111/jch.12734] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2015] [Revised: 09/21/2015] [Accepted: 09/27/2015] [Indexed: 01/19/2023]
Abstract
The authors aimed to evaluate the relationship between high-sensitivity C-reactive protein (hs-CRP) and presence of left ventricular hypertrophy and diastolic dysfunction in patients with hypertension. A total of 95 newly diagnosed hypertensive patients (mean age, 54±10 years) and 20 controls were included in this study. Patients were divided into four groups according to relative wall thickness as normal, concentric remodeling, concentric, and eccentric hypertrophy. hs-CRP was measured in all patients and serum hs-CRP level was shown to be increased in patients with hypertension compared with controls (0.57 mg/dL vs 0.25 mg/dL, respectively; P<.001). The hs-CRP level was highest in patients with concentric hypertrophy. When compared with controls, serum hs-CRP level was significantly higher in patients with concentric remodeling (0.61±0.3 mg/dL vs 0.43±0.5 mg/dL, P<.030) and concentric hypertrophy (0.69±0.3 mg/dL vs 0.43±0.5 mg/dL, P<.032). The present study shows that serum hs-CRP is significantly associated with left ventricular diastolic function and concentric hypertrophy in patients with hypertension.
Collapse
Affiliation(s)
- Ergun Seyfeli
- Department of Cardiology, School of Medicine, Acibadem University, Istanbul, Turkey
| | - Bahadir Sarli
- Department of Cardiology, Research and Education Hospital, Kayseri, Turkey
| | - Hayrettin Saglam
- Department of Cardiology, Research and Education Hospital, Kayseri, Turkey
| | - Can Y Karatas
- Department of Cardiology, Research and Education Hospital, Darica, Kocaeli, Turkey
| | - Eyup Ozkan
- Department of Cardiology, Research and Education Hospital, Kayseri, Turkey
| | - Mehmet Ugurlu
- Department of Cardiology, Research and Education Hospital, Kayseri, Turkey
| |
Collapse
|
5
|
Sex-Specific Mediating Role of Insulin Resistance and Inflammation in the Effect of Adiposity on Blood Pressure of Prepubertal Children. PLoS One 2015; 10:e0132097. [PMID: 26125190 PMCID: PMC4488421 DOI: 10.1371/journal.pone.0132097] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/15/2015] [Accepted: 06/10/2015] [Indexed: 12/18/2022] Open
Abstract
Objective To evaluate the association between obesity indices and blood pressure (BP) at 4 years of age, in each sex, and to quantify to which extent this association is mediated by inflammation and insulin resistance (IR). Materials and Methods We studied 1250 4-year-old children selected from the population-based birth cohort Generation XXI. Associations between body mass index (BMI) z-score and waist-to-height ratio (WHtR), office BP, inflammation (high sensitivity C-reactive protein) and IR (HOMA-IR index) were assessed. Path Analysis, a modified multivariate regression approach, was applied to test causal models and quantify direct and indirect effects of predictors of systolic (SBP) and diastolic BP (DBP). Results SBP and DBP increased significantly with BMI and WHtR in both sexes. There was a strong direct association (explaining 74.1-93.2% of the total association) of both measures of adiposity with SBP, in both sexes. This association was additionally indirectly mediated by IR, particularly regarding WHtR (20.5% in girls and 9.4% in boys). Mediation by inflammation did not reach statistical significance in either sex. Regarding DBP, the direct effect of adiposity was strong (>95% for BMI and WHtR in boys) and the mediation by IR was much smaller in boys than in girls. Discussion The direct association between adiposity and BP in healthy 4-year-old children is strong and IR plays an important mediating role. The strength of effects of IR and inflammation suggests sex differences in the complex interplay between BP, adiposity and inflammation.
Collapse
|
6
|
Kramann N, Hasenfuß G, Seidler T. B-RAF and its novel negative regulator reticulocalbin 1 (RCN1) modulates cardiomyocyte hypertrophy. Cardiovasc Res 2014; 102:88-96. [PMID: 24492844 DOI: 10.1093/cvr/cvu024] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
AIM Activation of the kinase RAF and its downstream targets leads to cardiomyocyte hypertrophy. It has been hypothesized that B-RAF might be the main activator of MEK in various cell types. Therefore, the aim of this study was to investigate the role of B-RAF and its modulating factors in cardiomyocyte hypertrophy. METHODS AND RESULTS Neonatal rat cardiomyocytes were pre-treated with and without the specific B-RAF inhibitor SB590885 and then stimulated with phenylephrine to induce hypertrophy. Inhibition of B-RAF completely impeded the hypertrophic response and led to a significant reduction of MEK1/2 phosphorylation. By applying a eukaryotic cDNA expression screen, based on a dual-luciferase reporter assay for B-RAF activity measurement, we identified RCN1 as a new negative modulator of B-RAF activity. Adenovirus-mediated overexpression of reticulocalbin 1 (RCN1) completely impeded phenylephrine-induced hypertrophy and led to significantly reduced MEK1/2 phosphorylation. Conversely, adenoviral knockdown of RCN1 with a specific synthetic miRNA induced cardiomyocyte hypertrophy and significantly increased MEK1/2 phosphorylation. CONCLUSIONS In summary, our results show that the inhibition of B-RAF abolishes cardiomyocyte hypertrophy and we identified RCN1 as novel negative modulator of cardiomyocyte hypertrophy by inhibition of the mitogen-activated protein kinase signalling cascade. Our results show that B-RAF kinase activity is essential for cardiac hypertrophy and RCN1, its newly identified negative regulator, abolishes hypertrophic response of cardiomyocytes in vitro.
Collapse
Affiliation(s)
- Nadine Kramann
- Department of Cardiology and Pulmonology, University Medical Centre Göttingen, Robert-Koch-Straße 40, 37075 Göttingen, Germany
| | | | | |
Collapse
|
7
|
Harhay MO, Tracy RP, Bagiella E, Barr RG, Pinder D, Hundley WG, Bluemke DA, Kronmal RA, Lima JAC, Kawut SM. Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. Int J Cardiol 2013; 168:3818-24. [PMID: 23932860 DOI: 10.1016/j.ijcard.2013.06.028] [Citation(s) in RCA: 38] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/08/2013] [Revised: 06/03/2013] [Accepted: 06/20/2013] [Indexed: 10/26/2022]
Abstract
BACKGROUND/OBJECTIVES Inflammation contributes to the pathogenesis of disease associated with the left ventricle (LV); yet, our understanding of the effect of inflammation on the right ventricle (RV) is quite limited. METHODS AND RESULTS The relationships of C-reactive protein (CRP), interleukin-6 (IL-6) and fibrinogen with RV morphology and function (from cardiac MRI) were examined in participants free of clinical cardiovascular disease (n=4009) from the Multi-Ethnic Study of Atherosclerosis (MESA)-RV study. Multivariable regressions (linear, quantile [25th and 75th] and generalized additive models [GAM]) were used to examine the independent association of CRP, IL-6 and fibrinogen with RV mass, RV end-diastolic volume (RVEDV), RV end-systolic volume (RVESV), RV stroke volume (RVSV) and RV ejection fraction (RVEF). Unadjusted and adjusted analyses revealed strong inverse associations between both CRP and IL-6 with RV mass, RVEDV, RVESV and RVSV (all p<0.01); there were no associations with RVEF. These relationships remained significant after adjustment for the respective LV parameters and lung function. However, GAM models suggested that extreme values of CRP and IL-6 might have positive associations with RV parameters. Fibrinogen showed significant associations in unadjusted models, but no associations after adjustment or in sensitivity analyses. CONCLUSION Levels of CRP and IL-6 are independently associated with RV morphology even after adjustment for the respective LV measure in this multi-ethnic population free of clinical cardiovascular disease. Systemic inflammation may contribute to RV structural changes independent of effects on the LV.
Collapse
Affiliation(s)
- Michael O Harhay
- Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Abstract
Childhood HTN (hypertension) has become a widely investigated topic within the last decade due to its increasing prevalence. In the present review, we examine new developments and trends that have significantly contributed to aetiology, diagnosis, evaluation and management of childhood HTN. Many recent reports document an increasing prevalence of HTN, mainly essential HTN, in children worldwide. This is probably related to the increase of childhood obesity, although obesity is not the only factor. Evidence has been accumulating to suggest a rather complex interplay between obesity, uric acid level, dietary sodium intake, inflammation, inheritance and other factors, which lead to increased risk of developing HTN in childhood and adulthood. The detection and monitoring of HTN has significantly improved with the use of ABPM (ambulatory blood pressure monitoring), which allows not only for a more accurate classification and staging of HTN, but also for the calculation of more sophisticated parameters such as the AASI (ambulatory arterial stiffness index). Measurement of arterial stiffness enables assessment of arterial dysfunction, which may precede structural vascular changes evaluated by carotid intima media thickness. Sustained HTN eventually leads to end-organ damage [LVH (left ventricular hypertrophy), central nervous system], which in turn increases the risk of cardiovascular morbidity and mortality. New developments in childhood HTN, as outlined in the present review, will hopefully contribute to better screening and management of HTN in children.
Collapse
|
9
|
C-reactive protein gene variant and the human left ventricular growth response to exercise: data from The LARGE Heart Study. J Cardiovasc Pharmacol 2010; 55:26-9. [PMID: 19834334 DOI: 10.1097/fjc.0b013e3181c37d2d] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Abstract
OBJECTIVE Increased levels of C-reactive protein (CRP) are associated with left ventricular (LV) hypertrophy. This association may be causal (either directly or indirectly) or simply a confounder resulting from the recognized relationship between CRP and vascular disease. We attempted to clarify this issue, by assessing the association of a variant of the CRP gene with exercise-induced left ventricular hypertrophy in young healthy males: homozygosity for the T (rather than C) allele of the CRP +1444C>T gene variant is associated with serum CRP levels which are 0.68 mg/L higher than carriers of the C allele. METHODS AND RESULTS LV mass was measured using cardiovascular magnetic resonance in 301 army recruits before and after an identical 12-week physical training program. Subjects were genotyped for the CRP +1444C>T gene variant. LV mass was 164.25 +/-24.52 g at entry and increased with training (+3.77 +/- 10.77 g). This increase was greatest among those homozygous for the rare T allele (+8.17 6 12.09 vs. +3.37 6 10.58 for TT genotype vs. C-allele carriers respectively, P = 0.033). CONCLUSIONS CRP genotype is associated with a greater LV growth to exercise, supporting a causal association between CRP and LV growth. Whether such an association might be directly mediated or results from alterations in phenotypes which themselves drive LV growth (for instance, altered arterial compliance) is not clear.
Collapse
|
10
|
Zhang R, Zhang YY, Huang XR, Wu Y, Chung AC, Wu EX, Szalai AJ, Wong BC, Lau CP, Lan HY. C-Reactive Protein Promotes Cardiac Fibrosis and Inflammation in Angiotensin II–Induced Hypertensive Cardiac Disease. Hypertension 2010; 55:953-60. [DOI: 10.1161/hypertensionaha.109.140608] [Citation(s) in RCA: 81] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Rongxin Zhang
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Yuan Yuan Zhang
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Xiao R. Huang
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Yin Wu
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Arthur C.K. Chung
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Ed Xuekui Wu
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Alexander J. Szalai
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Benjamin C.Y. Wong
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Chu-Pak Lau
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| | - Hui Y. Lan
- From the Departments of Medicine (R.Z., Y.Y.Z., X.R.H., A.C.K.C., B.C.Y.W., C.-P.L., H.Y.L.) and Electrical and Electronic Engineering (Y.W., E.X.W.), University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine and Therapeutics and Li Ka Shing Institute of Health Sciences (X.R.H., A.C.K.C., H.Y.L.), Chinese University of Hong Kong, Hong Kong Special Administrative Region, China; Department of Medicine (A.J.S.), University of Alabama at Birmingham, Birmingham, Ala
| |
Collapse
|
11
|
Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol 2008; 29:580-4. [PMID: 18046596 DOI: 10.1007/s00246-007-9153-4] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2007] [Revised: 09/05/2007] [Accepted: 10/26/2007] [Indexed: 10/22/2022]
Abstract
Microalbuminuria (MA) and C-reactive protein (CRP) levels are predictors of increased risk for left ventricular hypertrophy (LVH). Whether the strength of association between CRP and LVH is comparable to that of MA in hypertensive children is unknown. CRP and MA were measured in 64 children and adolescents with essential hypertension (HTN). In the entire population, CRP and MA showed positive relations with body mass index (BMI) (r = 0.30, p = 0.04 and r = 0.32, p = 0.04, respectively), systolic blood pressure (SBP) (r = 0.63, p = 0.03 and r = 0.58, p = 0.03, respectively), and LVH (r = 0.86, p < 0.001 and r = 0.81, p < 0.001, respectively). Patients with LVH (n = 23) had significantly higher BMI (p = 0.32), increased SBP (p = 0.031), and higher levels of CRP (p < 0.001) and MA (p < 0.001) compared with those without LVH. Multiple linear regression analysis demonstrated that CRP (r = 2.11, p < 0.001), MA (r = 1.94, p < 0.003), BMI (r = 0.53, p = 0.02), and SBP (r = 0.48, p = 0.04) were significantly associated with LVH. By analysis of covariance, CRP and MA were significantly different between patients who had LVH and those without LVH after adjustment for age, gender, BMI, SBP, SBP index, and diastolic blood pressure (p < 0.001 for the two markers). In conclusion, the strength of association between LVH and CRP is comparable to that of MA in children and adolescents with essential HTN.
Collapse
|